Francine Lettre

Different molecular basis for fumarylacetoacetate hydrolase deficiency in the two clinical forms of hereditary tyrosinemia (type I).

Robert M. Tanguay, J P Valet, A. Lescault et al. · PubMed · 1990 · 98 citations

Type 1 hereditary tyrosinemia. Evidence for molecular heterogeneity and identification of a causal mutation in a French Canadian patient.

Daniel J. Phaneuf, Marie Lambert, Rachel Laframboise et al. · Journal of Clinical Investigation · 1992 · 83 citations · Full text

Metabolic Disorder, Genetics, Genetic Epidemiology +21

Geographical and Ethnic Distribution of Mutations of the Fumarylacetoacetate Hydrolase Gene in Hereditary Tyrosinemia Type 1

Francesca Angileri, Anne Bergeron, Geneviève Morrow et al. · JIMD Reports · 2014 · 69 citations · Full text

Frequent mutation reversion inversely correlates with clinical severity in a genetic liver disease, hereditary tyrosinemia

Sylvie I. Demers, Pierre Russo, Francine Lettre et al. · Human Pathology · 2003 · 69 citations

Hereditary Tyrosinemia, Mendelian Disorder, Hepatology +11

Different Clinical Forms of Hereditary Tyrosinemia (Type I) in Patients with Identical Genotypes

Jacques Poudrier, Francine Lettre, Charles R. Scriver et al. · Molecular Genetics and Metabolism · 1998 · 55 citations

Hereditary Tyrosinemia, Different Clinical Forms, Genetic Disorder +9